During a panel discussion at the MedCity News INVEST Digital Health Conference, executives shared the top challenges they're facing in the consumer diagnostic testing space. These challenges include funding and encouraging behavior change.
NOWDiagnostics’ First To Know has FDA De Novo marketing authorization as a new test for syphilis. The at-home product needs only a single drop of blood to test for this sexually transmitted infection.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
NOWDiagnostics CEO Kevin Clark shares about the company's single fingertip-prick blood testing that could change the way we diagnose diseases as well as detect pregnancy.